Related references
Note: Only part of the references are listed.Interferon-gamma Inhibits Melanogenesis and Induces Apoptosis in Melanocytes: A Pivotal Role of CD8+ Cytotoxic T Lymphocytes in Vitiligo
Lili Yang et al.
ACTA DERMATO-VENEREOLOGICA (2015)
Tumour necrosis factor-α inhibition can stabilize disease in progressive vitiligo
K. C. Webb et al.
BRITISH JOURNAL OF DERMATOLOGY (2015)
Differential expression of mRNA for T-bet and GATA-3 transcription factors in peripheral blood mononuclear cells of patients with vitiligo
A. Nouri-Koupaee et al.
CLINICAL AND EXPERIMENTAL DERMATOLOGY (2015)
Tofacitinib Citrate for the Treatment of Vitiligo A Pathogenesis-Directed Therapy
Brittany G. Craiglow et al.
JAMA DERMATOLOGY (2015)
Segmental vitiligo after infliximab use for rheumatoid arthritis - A case report
Clarissa Luiza Dalla Bernardina Carvalho et al.
ANAIS BRASILEIROS DE DERMATOLOGIA (2014)
A Quantitative Increase in Regulatory T Cells Controls Development of Vitiligo
Shilpak Chatterjee et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2014)
The skin tissue is adversely affected by TNF-alpha blockers in patients with chronic inflammatory arthritis: a 5-year prospective analysis
Natalia P. Machado et al.
CLINICS (2013)
Comorbidities Associated with Vitiligo: A Ten-Year Retrospective Study
Vaneeta M. Sheth et al.
DERMATOLOGY (2013)
Tumor necrosis factor-α in vitiligo: direct correlation between tissue levels and clinical parameters
Nancy H. Kim et al.
CUTANEOUS AND OCULAR TOXICOLOGY (2011)
Vitiligo: A comprehensive overview Part I. Introduction, epidemiology, quality of life, diagnosis, differential diagnosis, associations, histopathology, etiology, and work-up
Ali Alikhan et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2011)
Vitiligo in a patient receiving infliximab for refractory ulcerative colitis
Waleed A. Ismail et al.
Arab Journal of Gastroenterology (2011)
Vitiligo during Treatment of Crohn's Disease with Adalimumab: Adverse Effect or Co-Occurrence?
Celia Posada et al.
CASE REPORTS IN DERMATOLOGY (2011)
Cutaneous events during anti-TNF alpha therapy: A prospective observational study of 41 cases
N. Bonnet et al.
ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE (2010)
Reduced skin homing by functional Treg in vitiligo
Jared Klarquist et al.
PIGMENT CELL & MELANOMA RESEARCH (2010)
Psoriatic Skin Lesions Induced by Tumor Necrosis Factor Antagonist Therapy: Clinical Features and Possible Immunopathogenesis
Angelique N. Collamer et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2010)
Cutaneous side effects of anti-tumor necrosis factor biologic therapy: A clinical review
Aikaterini-Evaggelia Moustou et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2009)
Use of anti-tumor necrosis factor agents: A possible therapy for vitiligo
Yajie Lv et al.
MEDICAL HYPOTHESES (2009)
Vitiligo
Alain Taieb et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Immune-mediated skin lesions in patients treated with anti-tumour necrosis factor alpha inhibitors
S. A. Exarchou et al.
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY (2009)
Vitiligo improvement in a patient with Ankylosing spondylitis treated with infliximab
J. -Abraham Simon et al.
DERMATOLOGY (2008)
Impaired PI3K/Akt activation-mediated NF-κB inactivation under elevated TNF-α is more vulnerable to apoptosis in vitiliginous Keratinocytes
Nan-Hyung Kim et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2007)
NALP1 in vitiligo-associated multiple autoimmune disease
Ying Jin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Increased tumor necrosis factor alpha (TNF-α) and interleukin 1 alpha (IL1-α) levels in the lesional skin of patients with nonsegmental vitiligo
Ahu Birol et al.
INTERNATIONAL JOURNAL OF DERMATOLOGY (2006)
Up regulation of the production of tumour necrosis factor α and interferon γ by T cells in ankylosing spondylitis during treatment with etanercept
J Zou et al.
ANNALS OF THE RHEUMATIC DISEASES (2003)
New insights into the pathogenesis of vitiligo: Imbalance of epidermal cytokines at sites of lesions
S Moretti et al.
PIGMENT CELL RESEARCH (2002)
Impaired Th1 cytokine production in spondyloarthropathy is restored by anti-TNFα
D Baeten et al.
ANNALS OF THE RHEUMATIC DISEASES (2001)
Share Paper
